Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Huma Joins Forces With Independent Healthcare Provider to Launch Virtual Ward Service for the NHS
Huma are partnering with Xyla Elective Care, a national provider of NHS England-funded elective services, […]
Elucid Raises $27 Million Series B Funding Round to Commercialize a New Paradigm in Heart Disease Diagnosis
Elucid, a company developing a novel, non-invasive medical software to comprehensively characterize cardiovascular disease, announced […]
BioMech, ēlizur Announce Partnership Integrating AI-enabled Motion Analytics into Physical Therapy Solution
BioMech Health, a division of BioMech Holdings, LLC, and ēlizur, a leading musculoskeletal solutions provider, announced today a […]
Idoven Raises $19.8 Million in Funding to Redefine Detection and Precision Medicine of Cardiovascular Diseases with AI
Idoven, a pioneering health tech company advancing early detection and precision medicine of cardiovascular disease, […]
Optibrium Receives Further Investment From Kester Capital
Optibrium™, a developer of software for drug discovery, today announced it has secured further investment […]
MicroTransponder Raises $53M, Appoints New CEO
MicroTransponder®, Inc. closed an oversubscribed $53 million Series E funding round led by US Venture Partners (USVP), a multi-stage investment […]
Börje Haraldsson Appointed Ceo of Oncorena AB
Oncorena AB, which is developing a new and potentially groundbreaking treatment for patients with advanced […]
3Z Closes $2 Million Funding for Preclinical Development of Novel ADHD and Insomnia Therapeutics Identified by 3Z´s Zebrafish Drug Discovery Platform
3Z, a Reykjavik based drug discovery company is pleased to announce the closure of a $2 million funding round […]
Therorna Completes Series A Financing to Accelerate Pipeline Development and Clinical Transformation of circRNA-based Platform
Therorna Inc., a China-based biotech company specialized in the development of cutting-edge circular RNA (or circRNA) […]
Fluent BioSciences and NanoCellect Announce Joint Collaboration to Improve Resolution of Single-cell RNA Sequencing Analysis of Rare Cell Populations
Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more